Development of a versatile oncolytic virus platform for local intra-tumoural expression of therapeutic transgenes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of a versatile oncolytic virus platform for local intra-tumoural expression of therapeutic transgenes

Published:2017-05-18 Issue:5 Volume:12 Page:e0177810
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Marino Nalini,Illingworth Sam,Kodialbail Prithvi,Patel Ashvin,Calderon Hugo,Lear Rochelle,Fisher Kerry D.,Champion Brian R.,Brown Alice C. N.^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference42 articles.

1. Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma;RH Andtbacka;J Clin Oncol,2015

2. Talimogene Laherparepvec: First Global Approval;SL Greig;Drugs,2016

3. Oncolytic Viruses in Cancer Treatment: A Review;SE Lawler;JAMA Oncol,2016

4. Trial Watch-Oncolytic viruses and cancer therapy;J Pol;Oncoimmunology,2016

5. Oncolytic viruses-immunotherapeutics on the rise;BA Keller;J Mol Med (Berl),2016

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and application of oncolytic viruses as the nemesis of tumor cells;Frontiers in Microbiology;2023-06-12

2. Infection of non-cancer cells: A barrier or support for oncolytic virotherapy?;Molecular Therapy - Oncolytics;2022-03

3. T-SIGn tumor reengineering therapy and CAR T cells synergize in combination therapy to clear human lung tumor xenografts and lung metastases in NSG mice;OncoImmunology;2022-02-10

4. Safety and efficacy of the tumor-selective adenovirus enadenotucirev with or without paclitaxel in platinum-resistant ovarian cancer: a phase 1 clinical trial;Journal for ImmunoTherapy of Cancer;2021-12

5. Oncolytic Virotherapy: From Bench to Bedside;Frontiers in Cell and Developmental Biology;2021-11-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3